FDA Inspection 1315790 — Octapharma Plasma, Inc.
The FDA completed an inspection of Octapharma Plasma, Inc. on April 17, 2026 in Vancouver, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 17, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Vancouver, WA (United States)